CDK2-IN-13

CDK2-IN-13

• CAS Number: 101622-53-1
• UNSPSC Description: CDK2-IN-13 (Compound 15) is a CDK2 inhibitor with an IC50 of 12 µM. CDK2-IN-13 can be used in research of cancer[1].
• Target Antigen: CDK
• Type: Reference compound
• Related Pathways: Cell Cycle/DNA Damage
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/cdk2-in-13.html
• Purity: 98.20
• Solubility: DMSO : 11.11 mg/mL (ultrasonic;warming;adjust pH to 11 with NaOH;heat to 60°C)
• Smiles: CN1C=NC2=C(N=C(N=C21)Cl)NCC3=CC=CC=C3
• Molecular Weight: 273.727
• References & Citations: [1]Havlícek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40(4):408-12.
• Shipping Conditions: Room Temperature
• Storage Conditions: 4°C (Powder, sealed storage, away from moisture and light)
• Clinical Information: No Development Reported